The federal agency’s new alert is about counterfeit drugs claiming to have semaglutide — the key ingredient in weight loss ...

Ozempic and other similar drugs must be injected. Messer describes the needle as “small, the size of two human hairs.” ...

After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...

Now that the shortage of semaglutide injection products has been resolved, the Food and Drug Administration (FDA) will restrict third parties ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...

The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all ...

The FDA has declared that the shortage of popular weight-loss drugs, including Ozempic and Wegovy, is officially over.

Recent research throws into question whether GLP-1 drugs increase the risk of certain types of thyroid cancer.

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.

Novo Nordisk’s weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom ...

The FDA has declared that the shortage of popular weight-loss drugs, including Ozempic and Wegovy, is officially over. After nearly three years of high demand and supply chain issues, semaglutide ...